Status:

RECRUITING

Respiratory Virus Sampling and Repository

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Influenza

COVID-19

Eligibility:

All Genders

3+ years

Brief Summary

Background: Respiratory viruses, like the flu or COVID-19, cause significant illness and death worldwide. Researchers want to collect samples from people with respiratory virus infections. The sample...

Detailed Description

Study Description: Retrospective and prospective samples from participants will be obtained to isolate respiratory viruses for use in laboratory assays, animal experiments, development of challenge v...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Aged 3 years or older.
  • Documented or suspected infection with a respiratory virus.
  • Stated willingness to comply with all study procedures for the duration of the study.
  • EXCLUSION CRITERIA:
  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • 1\. Any condition that, in the opinion of the investigator, would compromise the safety of the study participant or staff, or would prevent proper conduct of the study.
  • Non-English Speaking Participants: This study will enroll non-English speaking participants.
  • For non-English speaking participants, the study will be explained to the participant/family through an interpreter, in the presence of the study team, in the language understood by the participant/family. The short form in the language understood by the participant/family will be signed by the participant/family or LAR and the interpreter, and the consent will be signed by the consenting provider and the interpreter.

Exclusion

    Key Trial Info

    Start Date :

    August 11 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2031

    Estimated Enrollment :

    20000 Patients enrolled

    Trial Details

    Trial ID

    NCT05266222

    Start Date

    August 11 2022

    End Date

    December 31 2031

    Last Update

    October 9 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892

    2

    NIH Building 33 (NIAID)

    Bethesda, Maryland, United States, 20892